Suppr超能文献

[慢性粒细胞白血病患者在接受来自另一位无关供体的初次移植后因移植物排斥反应成功接受来自一位一位点HLA不匹配无关供体的二次移植]

[Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].

作者信息

Tanaka M, Kanamori H, Kuwabara H, Yamaji S, Kamijo A, Taguchi J, Fujita H, Fujisawa S, Matsuzaki M, Mohri H, Ishigatsubo Y

机构信息

First Department of Internal Medicine, Yokohama City University School of Medicine.

出版信息

Rinsho Ketsueki. 2001 Aug;42(8):656-8.

Abstract

We report a patient with chronic myelogenous leukemia who received a second transplant from a one-locus HLA-mismatched unrelated donor after rejection of an initial bone marrow graft. For the first transplant, HLAs were fully matched, conditioning with busulfan + cyclophosphamide (CY) was applied, and cyclosporin A + short-term methotrexate (sMTX) was used for prophylaxis against GVHD. A complete chimera was not obtained, and the graft was rejected on day 122. For the second transplant, there was a one-HLA locus (DR) mismatch, conditioning was done with total body irradiation + cytarabine + CY, and GVHD prophylaxis consisted of FK506 + sMTX. Engraftment was obtained on day 27, and no graft failure was occurred at the time of writing. This case suggests that strong immunosuppression may have prevented rejection of the second bone marrow graft.

摘要

我们报告了一名慢性粒细胞白血病患者,该患者在初次骨髓移植被排斥后,接受了来自一位HLA单位点不匹配的无关供者的第二次移植。第一次移植时,HLA完全匹配,采用白消安+环磷酰胺(CY)进行预处理,并使用环孢素A+短期甲氨蝶呤(sMTX)预防移植物抗宿主病(GVHD)。未获得完全嵌合体,移植物在第122天被排斥。第二次移植时,存在一个HLA位点(DR)不匹配,采用全身照射+阿糖胞苷+CY进行预处理,GVHD预防采用FK506+sMTX。在第27天实现植入,在撰写本文时未发生移植物失败。该病例表明,强效免疫抑制可能预防了第二次骨髓移植的排斥反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验